LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$80.02 USD
+1.27 (1.61%)
Updated May 22, 2024 04:00 PM ET
After-Market: $80.09 +0.07 (0.09%) 7:58 PM ET
1-Strong Buy of 5 1
C Value C Growth C Momentum C VGM
Brokerage Reports
LeMaitre Vascular, Inc. [LMAT]
Reports for Purchase
Showing records 1 - 20 ( 189 total )
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Resuming Coverage - Initiating Coverage
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for LMAT 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Medical Technology: Suspending Coverage of 21 Companies
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
1Q23 Recap - Hitting on All Cylinders (Volume/Price)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S